1
|
Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El‐abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV. What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study. Cancer Med 2021; 11:332-339. [PMID: 34921525 PMCID: PMC8729061 DOI: 10.1002/cam4.4449] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Revised: 10/08/2021] [Accepted: 11/10/2021] [Indexed: 11/06/2022] Open
Affiliation(s)
- Sara Pizzamiglio
- Bioinformatics and Biostatistics Unit Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Giulia Cosentino
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Chiara M. Ciniselli
- Bioinformatics and Biostatistics Unit Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Loris De Cecco
- Integrated Biology Platform Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Alessandra Cataldo
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Ilaria Plantamura
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Tiziana Triulzi
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | | | | | | | - Paolo Nuciforo
- Molecular Oncology GroupVall d'Hebron Institute of Oncology (VHIO) Barcelona Spain
| | - Jens Huober
- Breast Center Cantonal Hospital St. Gallen Switzerland
| | | | - David L. Rimm
- Department of Pathology Yale University School of Medicine New Haven Connecticut USA
| | | | - Maria Grazia Daidone
- Biomarkers Unit Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Paolo Verderio
- Bioinformatics and Biostatistics Unit Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Elda Tagliabue
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Serena Di Cosimo
- Biomarkers Unit Department of Applied Research and Technological Development Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| | - Marilena V. Iorio
- Molecular Targeting Unit Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
| |
Collapse
|